{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T13:17:40Z","timestamp":1763644660201,"version":"3.43.0"},"reference-count":62,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T00:00:00Z","timestamp":1748131200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MedComm"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>This open\u2010label, single\u2010arm phase II study assessed the safety and efficacy of sequential hypofractionated radiotherapy (RT) followed by zimberelimab and R\u2010GemOx (rituximab, gemcitabine, oxaliplatin) in patients with primary refractory diffuse large B\u2010cell lymphoma (DLBCL). Fourteen patients were enrolled between June 2022 and December 2023, with 13 included in the analysis. RT doses of 36 and 24\u00a0Gy were delivered to the gross and target volumes in 12 fractions, followed by zimberelimab and R\u2010GemOx. The overall response rate within the irradiated field was 92.3%, and a complete response (CR) was achieved by 61.5% of patients; however, 38.5% experienced disease progression. Treatment\u2010related toxicities were manageable, primarily comprising mild leukocytopenia. Digital spatial profiling revealed 53 differentially expressed genes in CD20\u2010rich lymphoma regions and 93 in CD3\u2010rich T cell regions in non\u2010CR patients. Reactome analysis identified key immune system pathways. T cell infiltration correlated with treatment efficacy, and multiplex immunohistochemistry validated immune pathways as potential therapeutic targets. This study demonstrated the promising role of RT combined with immunochemotherapy in refractory DLBCL and suggests immune pathways as critical targets to improve treatment outcomes.<\/jats:p>","DOI":"10.1002\/mco2.70225","type":"journal-article","created":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T03:00:41Z","timestamp":1748142041000},"source":"Crossref","is-referenced-by-count":1,"title":["Phase II Trial of Hypofractionated Radiotherapy and Immunochemotherapy in Primary Refractory Diffuse Large B\u2010Cell Lymphoma: Preliminary Results and Insights from Digital Spatial Profiling"],"prefix":"10.1002","volume":"6","author":[{"given":"Yong","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology Fujian Medical University Union Hospital, Fujian Key Laboratory of Intelligent Imaging and Precision Radiotherapy for Tumors (Fujian Medical University), Clinical Research Center for Radiology and Radiotherapy of Fujian Province (Digestive, Hematological and Breast Malignancies)  Fuzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Pulmonary Oncology Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University  Wuhan China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao\u2010Mei","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Pathology Fujian Medical University Union Hospital  Fuzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si\u2010Lin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology Fujian Medical University Union Hospital, Fujian Key Laboratory of Intelligent Imaging and Precision Radiotherapy for Tumors (Fujian Medical University), Clinical Research Center for Radiology and Radiotherapy of Fujian Province (Digestive, Hematological and Breast Malignancies)  Fuzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui\u2010Zhi","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology Fujian Medical University Union Hospital, Fujian Key Laboratory of Intelligent Imaging and Precision Radiotherapy for Tumors (Fujian Medical University), Clinical Research Center for Radiology and Radiotherapy of Fujian Province (Digestive, Hematological and Breast Malignancies)  Fuzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology Fujian Medical University Union Hospital, Fujian Key Laboratory of Intelligent Imaging and Precision Radiotherapy for Tumors (Fujian Medical University), Clinical Research Center for Radiology and Radiotherapy of Fujian Province (Digestive, Hematological and Breast Malignancies)  Fuzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiang\u2010Rui","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Hematology Fujian Medical University Union Hospital, Fujian Institute of Hematology, Fujian Provincial Key Laboratory on Hematology  Fuzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian\u2010Lan","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology Fujian Medical University Union Hospital, Fujian Key Laboratory of Intelligent Imaging and Precision Radiotherapy for Tumors (Fujian Medical University), Clinical Research Center for Radiology and Radiotherapy of Fujian Province (Digestive, Hematological and Breast Malignancies)  Fuzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology Fujian Medical University Union Hospital, Fujian Key Laboratory of Intelligent Imaging and Precision Radiotherapy for Tumors (Fujian Medical University), Clinical Research Center for Radiology and Radiotherapy of Fujian Province (Digestive, Hematological and Breast Malignancies)  Fuzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu\u2010Ping","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology Fujian Medical University Union Hospital, Fujian Key Laboratory of Intelligent Imaging and Precision Radiotherapy for Tumors (Fujian Medical University), Clinical Research Center for Radiology and Radiotherapy of Fujian Province (Digestive, Hematological and Breast Malignancies)  Fuzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology Fujian Medical University Union Hospital, Fujian Key Laboratory of Intelligent Imaging and Precision Radiotherapy for Tumors (Fujian Medical University), Clinical Research Center for Radiology and Radiotherapy of Fujian Province (Digestive, Hematological and Breast Malignancies)  Fuzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian\u2010Xiu","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology Fujian Medical University Union Hospital, Fujian Key Laboratory of Intelligent Imaging and Precision Radiotherapy for Tumors (Fujian Medical University), Clinical Research Center for Radiology and Radiotherapy of Fujian Province (Digestive, Hematological and Breast Malignancies)  Fuzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology Fujian Medical University Union Hospital, Fujian Key Laboratory of Intelligent Imaging and Precision Radiotherapy for Tumors (Fujian Medical University), Clinical Research Center for Radiology and Radiotherapy of Fujian Province (Digestive, Hematological and Breast Malignancies)  Fuzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Si\u2010Qin","family":"Liao","sequence":"additional","affiliation":[{"name":"Department of PET\/CT Fujian Medical University Union Hospital  Fuzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin\u2010Hua","family":"Chen","sequence":"additional","affiliation":[{"name":"Follow\u2010Up Center Fujian Medical University Union Hospital  Fuzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai\u2010Ying","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Hematology The Third Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine, The Third People's Hospital of Fujian Province  Fuzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting\u2010Bo","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Hematology Fujian Medical University Union Hospital, Fujian Institute of Hematology, Fujian Provincial Key Laboratory on Hematology  Fuzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,5,25]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2027612"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21820"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011795"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(08)70002-0"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-03-276246"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(20)30222-2"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14813"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-03-769620"},{"issue":"7","key":"e_1_2_12_10_1","first-page":"2186","article-title":"Autologous Stem Cell Transplant in Fit Patients With Refractory or Early Relapsed Diffuse Large B\u2010Cell Lymphoma That Responded to Salvage Chemotherapy","volume":"109","author":"Tun A. M.","year":"2024","journal-title":"Haematologica"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707447"},{"key":"e_1_2_12_12_1","article-title":"Axicabtagene Ciloleucel as Second\u2010Line Therapy for Large B\u2010Cell Lymphoma","author":"Locke F. L.","year":"2021","journal-title":"New England Journal of Medicine"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27283"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27155"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2022.12.017"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2023.04.008"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.813832"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1200563"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2019.05.004"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00940"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-11837-2"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020006028"},{"key":"e_1_2_12_23_1","first-page":"171","article-title":"Does Bridging Radiation Therapy Affect the Pattern of Failure After CAR T\u2010Cell Therapy in Non\u2010Hodgkin Lymphoma?","author":"Saifi O.","year":"2021","journal-title":"Radiotherapy and Oncology"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2021.06.038"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03634-9"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/35000501"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa042040"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.07.0722"},{"key":"e_1_2_12_29_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.51.4505"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V124.21.393.393"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29113"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.61.7654"},{"key":"e_1_2_12_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2017.12.005"},{"key":"e_1_2_12_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000907"},{"key":"e_1_2_12_35_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.02063"},{"key":"e_1_2_12_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26500"},{"key":"e_1_2_12_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-023-00895-7"},{"key":"e_1_2_12_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.27630"},{"key":"e_1_2_12_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)01774-4"},{"issue":"1","key":"e_1_2_12_40_1","first-page":"142","article-title":"Atezolizumab Combined With Immunogenic Salvage Chemoimmunotherapy in Patients With Transformed Diffuse Large B\u2010Cell Lymphoma","volume":"110","author":"Othman T.","year":"2025","journal-title":"Haematologica"},{"issue":"9","key":"e_1_2_12_41_1","first-page":"2802","article-title":"Spotlight on Polatuzumab Vedotin: New Standards for Diffuse Large B\u2010Cell Lymphoma?","volume":"109","author":"Ghione P.","year":"2024","journal-title":"Haematologica"},{"key":"e_1_2_12_42_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2206913"},{"key":"e_1_2_12_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00066-024-02256-0"},{"key":"e_1_2_12_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(24)00023-8"},{"key":"e_1_2_12_45_1","doi-asserted-by":"publisher","DOI":"10.1200\/GO.23.00275"},{"key":"e_1_2_12_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2023.11.040"},{"key":"e_1_2_12_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2024.114062"},{"key":"e_1_2_12_48_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2022.1815"},{"key":"e_1_2_12_49_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024012599"},{"key":"e_1_2_12_50_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.243626"},{"key":"e_1_2_12_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2023.09.004"},{"key":"e_1_2_12_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2021.10.006"},{"key":"e_1_2_12_53_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abi4919"},{"key":"e_1_2_12_54_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-2949"},{"key":"e_1_2_12_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-024-01358-2"},{"key":"e_1_2_12_56_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.17_suppl.LBA7003"},{"key":"e_1_2_12_57_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.00766"},{"key":"e_1_2_12_58_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01825-0"},{"key":"e_1_2_12_59_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.8800"},{"key":"e_1_2_12_60_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-04-639336"},{"key":"e_1_2_12_61_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41596-024-01045-4"},{"key":"e_1_2_12_62_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41592-019-0667-5"},{"key":"e_1_2_12_63_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpz1.722"}],"container-title":["MedComm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mco2.70225","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T12:25:05Z","timestamp":1754396705000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/mco2.70225"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,25]]},"references-count":62,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10.1002\/mco2.70225"],"URL":"https:\/\/doi.org\/10.1002\/mco2.70225","archive":["Portico"],"relation":{},"ISSN":["2688-2663","2688-2663"],"issn-type":[{"type":"print","value":"2688-2663"},{"type":"electronic","value":"2688-2663"}],"subject":[],"published":{"date-parts":[[2025,5,25]]},"article-number":"e70225"}}